Developed Healthcare Sector Coupled with High Awareness Drives the North American Pen Needle Market

The North American Pen Needle market is anticipated to grow at a CAGR of 7.5% during the forecast period (2020-2026). North America has a vast potential for the treatment of diabetes owing to the presence of numerous companies and research institutes focused on the R&D regarding drug development and manufacturing. The pen needle industry growth is mainly influenced by factors such as a rise in the number of diabetic patients coupled with the awareness of diabetes care. In addition, according to IDF, in 2019, the prevalence of diabetes was around 13.3% of the total adult population in the region which is expected to increase up to 14.2% by 2030 and 15% by 2045. Thus, the increased prevalence of diabetes provides growth opportunities for the market during the forecast period.

Browse the full report description of "North American Pen Needle Market Size, Share & Trends Analysis Report By Type (Standard and Safety), By Therapy (Insulin, GLP-1, Growth Hormones), By Mode of Purchase (Retail and Non-Retail), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/north-american-pen-needle-market

Furthermore, the frequent advancements in the pen needles by the companies working across the region will also contribute to the high share of the regional market. In addition to this, the high awareness among people related to the availability of such products in the market for maintaining the diabetes level is further anticipated to contribute towards the growth of the North American pen needle market. Moreover, there is significant support from governments in the form of reimbursements for the government and private insurers which also encourages the treatment of diabetes among the regional population. 

Market Coverage

• The market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- 

o By Type

o By Therapy

o By Mode of Purchase

• Competitive Landscape- Becton, Dickinson and Co., Novo Nordisk A/S, Domrex Pharma, Inc., and others

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American Pen Needle Market Report Segment

By Type

• Standard Pen Needles
• Safety Pen Needles

By Therapy

• Insulin
• GLP-1
• Growth Hormones

By Mode of Purchase

• Retail
• Non-Retail

North American Pen Needle Market Report- Countries Covered

• US
• Canada

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/north-american-pen-needle-market